Cholangiocarcinoma: all 930 studies
Page 8 of 10. Open to participants first (292), then studies with results posted, then the rest; newest registration first within each.
- Percutaneous Hepatic Perfusion vs. Cisplatin/Gemcitabine in Patients With Intrahepatic CholangiocarcinomaStatus unknownNCT03086993Phase 2/3
- A Study of Cisplatin or Carboplatin With Gemcitabine Versus Gemcitabine Alone as Adjuvant Therapy in Patients With Resected or Ablation Intra-Hepatic CholangiocarcinomaWithdrawnNCT03081039Phase 3
- Adjuvant Capecitabine vs Gemcitabine Plus Cisplatin in Resected Extrahepatic CholangiocarcinomaCompletedNCT03079427Phase 2
- Nal-IRI With 5-fluorouracil (5-FU) and Leucovorin or Gemcitabine Plus Cisplatin in Advanced Biliary-tract CancerCompletedNCT03044587Phase 2
- Nal-IRI and 5-FU Compared to 5-FU in Patients With Cholangio- and Gallbladder Carcinoma Previously Treated With Gemcitabine-based TherapiesCompletedNCT03043547Phase 2
- Trial of Therapeutic Vaccine in Patients With CholangiocarcinomaStatus unknownNCT03042182Phase 1/2
- Surveillance Study for Early Detection of Cholangiocarcinoma (CCA) in Primary Sclerosing Cholangitis (PSC)CompletedNCT03041662
- A Study of Merestinib (LY2801653) in Japanese Participants With Advanced or Metastatic CancerCompletedNCT03027284Phase 1
- Safety and Tumoricidal Effect of Low Dose Foscan PDT in Patients With Inoperable Bile Duct CancersCompletedNCT03003065Phase 2
- A Phase 1 Study Evaluating the Safety of TRK-950 in Patients With Advanced Solid TumorsCompletedNCT02990481Phase 1
- Effectiveness of Prophylactic Antibiotics to Prevent Post Endoscopic Retrograde Cholangio Pancreatography Bacteremia in Biliary Obstruction PatientStatus unknownNCT02958059Not applicable
- Efficacy and Safety Study of PDT Using Deuteporfin for Unresectable Advanced Perihilar CholangiocarcinomaTerminatedNCT02955771Phase 2
- Proximal Roux-en-y Gastrojejunal Anastomosis on Delayed Gastric Emptying After Pylorus-resecting PancreaticoduodenectomyStatus unknownNCT02954302Not applicable
- Liver and Biliary Tumor Tissue RegistryTerminatedNCT02917759
- Extracellular RNA Markers of Liver Disease and CancerTerminatedNCT02908048
- Pancreatico-biliary Tumor Mutation Profiling in Bile SamplesCompletedNCT02893085
- Liver Transplantation for Early Intrahepatic CholangiocarcinomaTerminatedNCT02878473Phase 2
- Beacon BNX™ Endoscopic Ultrasound (EUS)-Needle vs SharkCore™ NeedleWithdrawnNCT02872831Not applicable
- Ricolinostat, Gemcitabine Hydrochloride, and Cisplatin in Treating Patients With Unresectable or Metastatic CholangiocarcinomaWithdrawnNCT02856568Phase 1
- Early Palliative Care in Patients With Metastatic Upper Gastrointestinal Cancers Treated With First-line ChemotherapyCompletedNCT02853474Phase 3
- Intra-luminal Radiofrequency Ablation for Inoperable Malignant Biliary StenosisCompletedNCT02841800Not applicable
- Molecularly Target Therapy With GEMOX in Advanced or Recurrent Extrahepatic Cholangiocarcinoma and Gallbladder CarcinomaStatus unknownNCT02836847Phase 2
- Nivolumab and Ipilimumab in Treating Patients With Rare TumorsActive, not recruitingNCT02834013Phase 2
- Superior Bilioenteric Anastomosis by Magnetic Compressive TechniqueStatus unknownNCT02801500Not applicable
- Clinical Trial of Adjuvant Chemotherapy Followed by Concurrent Chemoradiotherapy Compared With Adjuvant Chemotherapy Alone in Patients With Gallbladder Carcinoma and Extrahepatic CholangiocarcinomaStatus unknownNCT02798510Phase 3
- Analysis of Oncogenes in Intrahepatic Cholangiocarcinoma or Mixed Hepatocellular-Cholangiocarcinoma in Tumor Tissue SamplesCompletedNCT02762721
- WASH Trial: Intraoperative Lavage as a Treatment for Pancreatic CancerActive, not recruitingNCT02757859Not applicable
- CD8+ T Cell Therapy and Pembrolizumab in Treating Patients With Metastatic Gastrointestinal TumorsTerminatedNCT02757391Phase 1
- Metabolic Syndrome, Bile Acids, Hepatocellular Carcinoma and CholangiocarcinomaCompletedNCT02730611
- Photodynamic Therapy in Locally Advanced Hilar CholangiocarcinomaStatus unknownNCT02725073Phase 2
- A Study to Evaluate the Clinical Efficacy of JNJ-42756493 (Erdafitinib), A Pan-Fibroblast Growth Factor Receptor (FGFR) Tyrosine Kinase Inhibitor, In Asian Participants With Advanced Non-Small-Cell Lung Cancer, Urothelial Cancer, Esophageal Cancer Or CholangiocarcinomaCompletedNCT02699606Phase 2
- Radiofrequency Ablation Using Octopus Electrodes for Treatment of Focal Liver MalignanciesCompletedNCT02683538Phase 2
- Biliary Cancer in Italy: a Study on Cholangiocarcinoma cAUSEs and Risk FactorsStatus unknownNCT02665494
- A Study for Efficacy of Side-by-side Compared to Stent-in-stent Technique in the Endoscopic Management of Malignant Hilar Biliary ObstructionStatus unknownNCT02659852Not applicable
- Unilateral Stenting Versus Bilateral Stenting for Malignant Hilar Biliary ObstructionCompletedNCT02649712Not applicable
- Efficacy and Safety of Endobiliary Radiofrequency Ablation by Using a Novel RF Catheter (ELRA®) on Maintaining the Patency of Endobiliary Metal Drainage in Patients With Malignant Biliary Strictures : A Double-arm Comparable StudyStatus unknownNCT02646514Not applicable
- Study of Oral Ceritinib in Patients With ALK and ROS1 Activated Gastrointestinal MalignanciesTerminatedNCT02638909Phase 2
- Study of Pembrolizumab (MK-3475) in Participants With Advanced Solid Tumors (MK-3475-158/KEYNOTE-158)Active, not recruitingNCT02628067Phase 2
- Radiation Therapy in Treating Patients With Hepatocellular Carcinoma, Cholangiocarcinoma, or Liver Metastasis Who Have Impaired Liver FunctionTerminatedNCT02626312Phase 1
- ASLAN001 in Patients With Advanced or Metastatic Cholangiocarcinoma Who Progressed on at Least 1 Line of Systemic TherapyCompletedNCT02609958Phase 2
- Short-term Starvation vs. Normal Diet Before Chemotherapy of Solid TumorsStatus unknownNCT02607826Not applicable
- Endobiliary Radiofrequency Ablation With S-1 for Unresectable CholangiocarcinomaCompletedNCT02592538Not applicable
- Safety and Efficacy of Modified Folfirinox Versus Gemcis in Bile Duct TumoursCompletedNCT02591030Phase 2/3
- TACE Plus Tegafur Versus TACE for Intrahepatic Cholangiocarcinoma After Curative ResectionStatus unknownNCT02588755Not applicable
- Efficacy and Safety of Photodynamic Therapy for Unresectable CholangiocarcinomaCompletedNCT02585856Not applicable
- Endoscopic Biliary RFA of Malignant Bile Duct ObstructionStatus unknownNCT02582541Not applicable
- Basket Study of Entrectinib (RXDX-101) for the Treatment of Patients With Solid Tumors Harboring NTRK 1/2/3 (Trk A/B/C), ROS1, or ALK Gene Rearrangements (Fusions)Active, not recruitingNCT02568267Phase 2
- Oxaliplatin+Gemcitabine vs Capecitabine as Adjuvant Therapy for Intrahepatic CholangiocarcinomaStatus unknownNCT02548195Phase 3
- Effects of OXY111A in Primary and Secondary Hepato-Pancreato-Biliary NeoplasmStatus unknownNCT02528526Phase 1/2
- Conventional or Unconventional Lymph Node Dissection During Resection of Intrahepatic CholangiocarcinomaStatus unknownNCT02526771Not applicable
- Gemcitabine-Cisplatin-90Y TARE for Unresectable Intrahepatic CholangiocarcinomaTerminatedNCT02512692Not applicable
- Metformin And Chloroquine in IDH1/2-mutated Solid TumorsCompletedNCT02496741Phase 1/2
- Radiofrquency Ablation Combined With Cytokine-induced Killer Cells for the Patients With CholangiocarcinomaActive, not recruitingNCT02482454Phase 2/3
- A Study of BIND-014 in Patients With Urothelial Carcinoma, Cholangiocarcinoma, Cervical Cancer and Squamous Cell Carcinoma of the Head and NeckTerminatedNCT02479178Phase 2
- Radiofrequency Ablation for Biliopancreatic MalignancyCompletedNCT02468076Phase 2
- Second Line Chemotherapy FOLFIRINOX in Irresectable CholangiocarcinomaCompletedNCT02456714Phase 2
- Use of the EnLightTM and LightPathTM Imaging Systems in Gastrointestinal Tumour SurgeryWithdrawnNCT02446379
- In Vitro Models of Liver and Pancreatic CancerStatus unknownNCT02436564
- Melphalan for Use With the Hepatic Delivery System Treatment in Patients With Unresectable Hepatocellular Carcinoma or Intra Hepatic CholangiocarcinomaTerminatedNCT02415036Phase 2
- A Study of IDH305 in Patients With Advanced Malignancies That Harbor IDH1R132 MutationsActive, not recruitingNCT02381886Phase 1
- 18F-FSPG PET in Imaging Patients With Liver Cancer Before Undergoing Surgery or TransplantActive, not recruitingNCT02379377Phase 1
- Study of DKN-01 and Gemcitabine/Cisplatin in Patients With Carcinoma to Primary to the Intra- or Extra-Hepatic Biliary System or GallbladderCompletedNCT02375880Phase 1
- A Phase II Trial of LDK378 in ROS1 and /or ALK Over-expressed Advanced Intrahepatic or Hilar CholangiocarcinomaTerminatedNCT02374489Phase 2
- ABC-08: Phase Ib Trial of Acelarin in Combination With Cisplatin in Locally Advanced/ Metastatic Biliary Tract CancersCompletedNCT02351765Phase 1
- Genetic Analysis-Guided Dosing of FOLFIRABRAX in Treating Patients With Advanced Gastrointestinal CancerCompletedNCT02333188Phase 1
- Radioactive Stents for Treatment of Unresectable Biliary Tract CancerStatus unknownNCT02238613Not applicable
- Liver Resection Versus Radio-chemotherapy-Transplantation for Hilar CholangiocarcinomaStatus unknownNCT02232932Not applicable
- A Study of BBI503 in Adult Patients With Advanced Hepatobiliary CancerCompletedNCT02232633Phase 2
- Next Generation Sequencing in Intrahepatic CholangiocarcinomaStatus unknownNCT02184871
- Safety Study of Liver Transplantation for Hilar CholangiocarcinomaStatus unknownNCT02178280Phase 1/2
- Anesthetic Agents and Acute Kidney Injury After Liver Resection SurgeryWithdrawnNCT02174575Phase 4
- Adjuvant Chemotherapy With Gemcitabine and Cisplatin Compared to Standard of Care After Curative Intent Resection of Biliary Tract CancerActive, not recruitingNCT02170090Phase 3
- Treatment for Bile Duct Cancer in the LiverCompletedNCT02167711Phase 2
- RFA RCT for Pancreatic or Bile Duct CancerTerminatedNCT02166190Not applicable
- Regorafenib Versus Placebo to Treat CholangiocarcinomaStatus unknownNCT02162914Phase 2
- Quantitative Real-time Ultrasound Elastography for Characterisation of Liver TumorsCompletedNCT02156700
- Study of CX-4945 in Combination With Gemcitabine and Cisplatin for Frontline Treatment of CholangiocarcinomaCompletedNCT02128282Phase 1/2
- Percutaneous Bilateral Versus Unilateral Metal Stent for Hilar CholangiocarcinomaStatus unknownNCT02108145Phase 2/3
- Study of Sildenafil as a Therapy for Fatigue in Pancreatic CancerWithdrawnNCT02106871Phase 1
- VEGF Signaling Promotes Cell Growth and Metastasis in Extrahepatic Cholangiocarcinoma in a VEGF Receptor Mediated Pathway (ECC)Status unknownNCT02103179
- Pancreatic Head and Peri-ampullary Cancer Laparoscopic vs Open Surgical Treatment Trial (PLOT)CompletedNCT02081131Not applicable
- Study of Orally Administered AG-120 in Subjects With Advanced Solid Tumors, Including Glioma, With an IDH1 MutationCompletedNCT02073994Phase 1
- Loop-tipped Guidewire in Selective Biliary CannulationCompletedNCT02028845Not applicable
- Phase I/IIa Study to Evaluate the Safety, PK, PD, and Preliminary Efficacy of PLX8394 in Patients With Advanced Cancers.TerminatedNCT02012231Phase 1
- Diagnosis of Bile Duct StricturesCompletedNCT02000999
- S-1 in Combination With Abraxane in Treating CholangiocarcinomaCompletedNCT01963325Phase 2
- Hepatic Arterial Infusion With Floxuridine and Dexamethasone in Combination With Gemcitabine as Adjuvant Treatment After Resection of Intrahepatic CholangiocarcinomaCompletedNCT01938729Phase 1
- Active Symptom Control Alone or With mFOLFOX Chemotherapy for Locally Advanced/ Metastatic Biliary Tract CancersCompletedNCT01926236Phase 3
- International Registry on Cholangiocarcinoma TreatmentStatus unknownNCT01920503
- VEGF Signaling Promotes Cell Growth and Metastasis in Intrahepatic Cholangiocarcinoma in a VEGF Receptor Mediated PathwayStatus unknownNCT01917370
- Prognosis of Resection and Radiotherapy in the Treatment of Intrahepatic Cholangiocarcinoma PatientsStatus unknownNCT01914289Not applicable
- Efficacy Study of Intra-hepatic Administration of Therasphere® in Association With Intravenous Chemotherapy to Treat CholangiocarcinomaCompletedNCT01912053Phase 2
- A Phase I/II Safety and Efficacy Study of PCI of Gemcitabine and Chemotherapy in Patients With CholangiocarcinomasCompletedNCT01900158Phase 1
- Sirolimus, Gemcitabine Hydrochloride, and Cisplatin in Treating Patients At High Risk for Cholangiocarcinoma Recurrence After Liver Transplant or SurgeryCompletedNCT01888302Phase 1
- Comparison Between Unilateral Versus Bilateral Stenting for Malignant Hilar Biliary Obstruction to Use a LCD StentWithdrawnNCT01875549Not applicable
- Role of Bile Duct Resection in Major Hepatectomy Due to Intrahepatic CholangiocarcinomaCompletedNCT01862276
- Selumetinib and Akt Inhibitor MK-2206 in Treating Patients With Refractory or Advanced Gallbladder or Bile Duct Cancer That Cannot Be Removed By SurgeryWithdrawnNCT01859182Phase 2
- Safety and Efficiency of Photodynamic Therapy for Blie Duct CarcinomaSuspendedNCT01859169
- Clinical Trial to Investigate the Efficacy of Treatment With Gemcitabine/Pazopanib in Patients With Biliary Tree CancerTerminatedNCT01855724Phase 2
- Endobiliary RFA for Unresectable Malignant Biliary StricturesCompletedNCT01844245Not applicable